SELECTOR : Heterogeneous graph network with convolutional masked autoencoder for multimodal robust prediction of cancer survival
Copyright © 2024 Elsevier Ltd. All rights reserved..
Accurately predicting the survival rate of cancer patients is crucial for aiding clinicians in planning appropriate treatment, reducing cancer-related medical expenses, and significantly enhancing patients' quality of life. Multimodal prediction of cancer patient survival offers a more comprehensive and precise approach. However, existing methods still grapple with challenges related to missing multimodal data and information interaction within modalities. This paper introduces SELECTOR, a heterogeneous graph-aware network based on convolutional mask encoders for robust multimodal prediction of cancer patient survival. SELECTOR comprises feature edge reconstruction, convolutional mask encoder, feature cross-fusion, and multimodal survival prediction modules. Initially, we construct a multimodal heterogeneous graph and employ the meta-path method for feature edge reconstruction, ensuring comprehensive incorporation of feature information from graph edges and effective embedding of nodes. To mitigate the impact of missing features within the modality on prediction accuracy, we devised a convolutional masked autoencoder (CMAE) to process the heterogeneous graph post-feature reconstruction. Subsequently, the feature cross-fusion module facilitates communication between modalities, ensuring that output features encompass all features of the modality and relevant information from other modalities. Extensive experiments and analysis on six cancer datasets from TCGA demonstrate that our method significantly outperforms state-of-the-art methods in both modality-missing and intra-modality information-confirmed cases. Our codes are made available at https://github.com/panliangrui/Selector.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:172 |
---|---|
Enthalten in: |
Computers in biology and medicine - 172(2024) vom: 26. März, Seite 108301 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pan, Liangrui [VerfasserIn] |
---|
Links: |
---|
Themen: |
Convolutional mask encoder |
---|
Anmerkungen: |
Date Completed 26.03.2024 Date Revised 26.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.compbiomed.2024.108301 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369821300 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369821300 | ||
003 | DE-627 | ||
005 | 20240326235903.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240317s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.compbiomed.2024.108301 |2 doi | |
028 | 5 | 2 | |a pubmed24n1349.xml |
035 | |a (DE-627)NLM369821300 | ||
035 | |a (NLM)38492453 | ||
035 | |a (PII)S0010-4825(24)00385-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pan, Liangrui |e verfasserin |4 aut | |
245 | 1 | 0 | |a SELECTOR |b Heterogeneous graph network with convolutional masked autoencoder for multimodal robust prediction of cancer survival |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.03.2024 | ||
500 | |a Date Revised 26.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Ltd. All rights reserved. | ||
520 | |a Accurately predicting the survival rate of cancer patients is crucial for aiding clinicians in planning appropriate treatment, reducing cancer-related medical expenses, and significantly enhancing patients' quality of life. Multimodal prediction of cancer patient survival offers a more comprehensive and precise approach. However, existing methods still grapple with challenges related to missing multimodal data and information interaction within modalities. This paper introduces SELECTOR, a heterogeneous graph-aware network based on convolutional mask encoders for robust multimodal prediction of cancer patient survival. SELECTOR comprises feature edge reconstruction, convolutional mask encoder, feature cross-fusion, and multimodal survival prediction modules. Initially, we construct a multimodal heterogeneous graph and employ the meta-path method for feature edge reconstruction, ensuring comprehensive incorporation of feature information from graph edges and effective embedding of nodes. To mitigate the impact of missing features within the modality on prediction accuracy, we devised a convolutional masked autoencoder (CMAE) to process the heterogeneous graph post-feature reconstruction. Subsequently, the feature cross-fusion module facilitates communication between modalities, ensuring that output features encompass all features of the modality and relevant information from other modalities. Extensive experiments and analysis on six cancer datasets from TCGA demonstrate that our method significantly outperforms state-of-the-art methods in both modality-missing and intra-modality information-confirmed cases. Our codes are made available at https://github.com/panliangrui/Selector | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Convolutional mask encoder | |
650 | 4 | |a Heterogeneous graph | |
650 | 4 | |a Missing | |
650 | 4 | |a Multimodal | |
650 | 4 | |a Robust | |
700 | 1 | |a Peng, Yijun |e verfasserin |4 aut | |
700 | 1 | |a Li, Yan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiang |e verfasserin |4 aut | |
700 | 1 | |a Liu, Wenjuan |e verfasserin |4 aut | |
700 | 1 | |a Xu, Liwen |e verfasserin |4 aut | |
700 | 1 | |a Liang, Qingchun |e verfasserin |4 aut | |
700 | 1 | |a Peng, Shaoliang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Computers in biology and medicine |d 1970 |g 172(2024) vom: 26. März, Seite 108301 |w (DE-627)NLM000382272 |x 1879-0534 |7 nnns |
773 | 1 | 8 | |g volume:172 |g year:2024 |g day:26 |g month:03 |g pages:108301 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.compbiomed.2024.108301 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 172 |j 2024 |b 26 |c 03 |h 108301 |